BOBA:CRYPTOCAPMarket Cap BOBA, $ Analysis
Data as of 2026-08-21 - not real-time
IDR 210.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
PT Formosa Ingredient Factory Tbk trades at IDR 210.00, with its moving averages tangled rather than clearly stacked — a neutral trend structure. The last 30 days have lost 17.3%. With RSI at 36.0 the momentum picture is approaching oversold, alongside a bullish MACD signal. Price has been bracketed by support at IDR 204.00 and resistance at IDR 244.00.
The shares look fair at 12.4 times earnings, though no sector average was available for comparison. Revenue is growing at 13.9% on a 10.4% profit margin. The 3.81% dividend yield looks covered by current payout levels.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 31.1%, a beta of -0.20 and a maximum drawdown of 42.5%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 5/10 long-term conviction.
The shares look fair at 12.4 times earnings, though no sector average was available for comparison. Revenue is growing at 13.9% on a 10.4% profit margin. The 3.81% dividend yield looks covered by current payout levels.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 31.1%, a beta of -0.20 and a maximum drawdown of 42.5%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 5/10 long-term conviction.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Trading below the 200-day average of 217.31
- MACD momentum is positive
- 30-day price change of -17.3%
Medium Term
1–3 yearsNeutral
Model confidence: 4/10
Key Factors
- Trading below the 200-day average of 217.31
- MACD momentum is positive
- P/E ratio of 12.4
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- Revenue growth of +13.9%
- P/E ratio of 12.4
- Dividend yield of 3.81%
Key Metrics & Analysis
Financial Health
Revenue Growth13.90%
Profit Margin10.44%
P/E Ratio12.4
ROE11.76%
ROA8.27%
Debt/Equity0.32
P/B Ratio1.4
Op. Cash FlowIDR35.9B
Free Cash FlowIDR7.9B
Technical Analysis
TrendNeutral
RSI36.0
SupportIDR 204.00
ResistanceIDR 244.00
MA 20IDR 218.50
MA 50IDR 256.96
MA 200IDR 217.32
MACDBullish
VolumeIncreasing
Fear & Greed Index93.25
Valuation
Fair ValueIDR 165.46
GradeFair
TypeValue
Dividend Yield3.81%
Risk Assessment
Beta-0.20
Volatility31.08%
Sector RiskLow
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.